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Direct observation of prion protein oligomer
formation reveals an aggregation mechanism with
multiple conformationally distinct species†
Jason C. Sang, a Ji-Eun Lee,‡a Alexander J. Dear,a Suman De,a Georg Meisl, a
Alana M. Thackray, b Raymond Bujdoso,b Tuomas P. J. Knowles a
and David Klenerman*a
The aggregation of the prion protein (PrP) plays a key role in the development of prion diseases. In the past
decade, a similar process has been associated with other proteins, such as Ab, tau, and a-synuclein, which
participate in other neurodegenerative diseases. It is increasingly recognized that the small oligomeric
species of aggregates can play an important role in the development of prion diseases. However,
determining the nature of the oligomers formed during the aggregation process has been experimentally
difficult due to the lack of suitable methods capable of the detection and characterization of the low
level of oligomers that may form. To address this problem, we have utilized single-aggregate methods to
study the early events associated with aggregation of recombinant murine PrP in vitro to approach the
bona fide process in vivo. PrP aggregation resulted in the formation of thioflavin T (ThT)-inactive and
ThT-active species of oligomers. The ThT-active oligomers undergo conversion from a Proteinase K
(PK)-sensitive to PK-resistant conformer, from which mature fibrils can eventually emerge. Overall, our
results show that single-aggregate methods can provide structural and mechanistic insights into PrP
aggregation, identify the potential species that mediates cytotoxicity, and reveal that a range of distinct
oligomeric species with different properties is formed during prion protein aggregation.
Introduction
Prion diseases, such as Creutzfeldt–Jakob diseases of humans,
bovine spongiform encephalopathy of cattle, and scrapie of
sheep, are a class of lethal neurodegenerative diseases. These
conditions are characterized by the accumulation of PrPSc, an
abnormal aggregated conformer of the normal host protein
PrPC.1 Prion diseases are transmissible between individuals of
the same or different species. The ‘protein-only’ hypothesis
states that the transmissible prion agent comprises solely of
PrPSc.2 The structural conversion of PrP involves the formation
of the brillar state of aggregates, which is generally considered
to be relatively resistant to Proteinase K (PK) and contains
a high cross-b sheet architecture.3–5 Despite numerous studies
in the last decades, the molecular events involved in the
aggregation process remain poorly dened. Increasing
evidence argues that other disease-associated proteins, such
as Ab, tau, and a-synuclein, also share a similar aggregation
mechanism with PrP6–11 that is classied as a ‘prion-like’
mechanism.
The early stage of bril formation has been associated with
low-molecular weight intermediates known as oligomers, which
is likely to be structurally heterogeneous and highly toxic to
cells.12,13 From biophysical studies in a-synuclein and yeast
prions, the oligomeric species has been revealed to undergo
a transition to a structurally more organized conformation and
is able to grow into brillar species.13–15 In mammalian prion
research, it remains unclear if this process occurs. Previous
studies have characterized recombinant PrP oligomers with
various approaches in vitro and shown that these are kinetically
stable and off the pathway to form brils.16–21 However,
depending on the conditions, the generation of oligomeric
species of PrP could result in various conformations and kinetic
properties. It is increasingly recognized that multiple
conformers of PrPSc may exist, including PK-sensitive and PK-
resistant species.22–26 Small soluble oligomeric species of PrPSc
have been shown to be the most efficient mediators of prion
infectivity27 and exert higher cytotoxicity than mature brils
both in vitro and in vivo.28
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The characterization of early events associated with the
aggregation process is extremely challenging, since these
aggregated species are highly heterogeneous and exist in
a transient manner. A recent study using the yeast prion Ure2
has shown that a single-aggregate analysis can provide a new
and informative approach to this complex area of prion biology
and establish a temporal relationship between the oligomeric
and mature brillar species.29 Two structurally distinct oligo-
meric species of Ure2 were identied that occur before bril
formation. In the case of mammalian PrP, prion infectivity and
neurotoxicity were suggested to involve different protein
aggregate species that appeared with different kinetics,22,30
while the species that contribute to the production of neuro-
toxicity were still undened. The proportional contribution of
PK-sensitive and PK-resistant PrPSc to these oligomers remains
unclear. Furthermore, there is little knowledge of the structural
heterogeneity and physical properties of PrP oligomers that
form at the early stage of PrP aggregation.
Aggregation-prone proteins in various neurodegenerative
diseases share a similar molecular phenomenon of nucleation,
growing, templating, and spreading. It is fundamentally
important to establish the nature and kinetics of misfolded
protein aggregation. The understanding of the molecular
details of the aggregation process and the identication of toxic
species of aggregates can contribute to potential therapeutic
targets to halt or retard their accumulation and resultant
toxicity. In our studies reported here, we have investigated the
structural transition of the oligomeric species formed during
aggregation of full-length recombinant murine PrP using
single-aggregate approaches. The application of this novel
approach has provided new insights into the early stages of PrP
aggregation in vitro, identifying ve oligomeric species with
distinct structural properties. With the use of the kinetic
modeling to the data, we have developed a multi-step kinetic
scheme for the early stage of bril formation of recombinant
PrP and described the time evolution of the oligomers observed
in a quantitative manner. These ndings illustrate the
complexity of PrP aggregation in vitro and provide a possible
aggregation mechanism for further studies in vivo.
Results
Single-aggregate imaging reveals the gradual formation of
small aggregates in early PrP aggregation
Mouse PrP aggregation was performed at 37 C with 200 rpm
under partially denaturing conditions of 2 M GdnHCl. Using
single-aggregate imaging based on total internal reection
uorescence microscopy (TIRFM),31 the aggregation reaction
was followed by taking aliquots at different time points from the
reaction mixture and mixing with 25 mM thioavin T (ThT) for
imaging (Fig. S1†). The solubility of full-length PrP restricted
the range of monomer concentrations applied. From 22.5 to
32.5 mM of the monomer concentration, we observed that the
overall intensity of PrP aggregates formed at the early stage of
aggregation (t < 8 h), as well as their total number, gradually
increased (Fig. S2a and b†). We also found that the rate of
increase of aggregate number depends on the initial protein
concentration. Only aggregates smaller than the diffraction
limit of 450 nm were detected at early stages of aggregation, and
no brils were detected until 24 h of aggregation. This result is
consistent with previously measured kinetic data using a bulk
solution under the same conditions.32
Early-formed PrP oligomers are structurally diverse
We have previously shown that spectrally-resolved PAINT (Points
Accumulation for Imaging in Nanoscale Topography), or sPAINT,
enables super-resolution imaging of protein aggregates with
a spatial resolution of 40 nm, as well as probing their surface
hydrophobicity.33 The spectral shi of the polarity-sensitive
uorescent dye Nile red (NR), which transiently and non-
specically binds to protein aggregates, allows the measure-
ment of relative surface hydrophobicity of individual protein
aggregates. The blue-shi of the NR emission indicates a more
hydrophobic surface, while the red-shi indicates a more
hydrophilic surface. sPAINT can be combined with ThT
imaging,34 making it possible to characterize PrP aggregates
based both on their amyloid structure and their hydrophobicity.
It is also possible to distinguish ThT-inactive species from ThT-
active species. To gain more insights into the early stages of
PrP aggregation, we applied this approach to visualize the
morphology of PrP aggregates, as well as to characterize the
temporal change in surface hydrophobicity. Aliquots at different
time points were taken from an aggregation reaction, diluted to
0.1 mM, and then loaded onto a coverslip for sPAINT experiments.
At early times, only small-sized PrP aggregates were detected
using sPAINT with NR dyes (Fig. 1a). No brillar species were
found at early times, which is consistent with the data as shown
in Fig. S1.† Using the super-resolved images, we measured the
length of individual aggregates for ThT-inactive and ThT-active
species and obtained their length distributions. ThT-active
species showed a gradual increase in their length with time,
while the length of ThT-inactive species also slightly increased
(Fig. 1b), despite their low number (Fig. 2c). The mature brils
collected at 48 h of aggregation showed a diverse range of length
distribution with an average of approximately 550 nm.
Using the median wavelength of NR uorescence of indi-
vidual PrP aggregates, we also measured the surface hydro-
phobicity of these aggregates at different time points for the
ThT-inactive and ThT-active species (Fig. 2a and d). The
surface of ThT-inactive species was found to be more hydro-
phobic compared to that of ThT-active species at each time
point. In addition, the surface hydrophobicity of the ThT-
inactive species gradually increased with time, which sug-
gested a structural reorganization occurred during PrP aggre-
gation. However, the ThT-inactive species only constituted
a small fraction of all aggregates (Fig. 2c). In contrast, the
dominant ThT-active aggregates showed no clear changes in
hydrophobicity with time. To gain more insights into the
aggregate conformations, we plotted the hydrophobicity land-
scapes of individual aggregates against their length (Fig. 2b).
ThT-active PrP aggregates were shown to grow in size with
similar surface hydrophobicity at the early stages of
aggregation.
This journal is © The Royal Society of Chemistry 2019 Chem. Sci., 2019, 10, 4588–4597 | 4589
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The difference between the surface structure of ThT-inactive
and ThT-active aggregates was more clearly visualized by
combining the hydrophobicity landscapes from 0.5, 3, to 8 h
(Fig. 3). While ThT-inactive aggregates were generally less than
80 nm in length, ThT-active aggregates were longer with a wider
range of lengths, and their hydrophobicity was similar to that of
mature brils collected at 48 h. This suggests that ThT-active
aggregates were structurally more similar to mature brils.
The total number of PrP aggregates detected using sPAINT
showed only small changes with time (Fig. 2c). This is consis-
tent with TIRF data (Fig. S2b†), which suggested that only
a small fraction of PrP aggregates that formed at early stages of
the aggregation ultimately grow into mature brils. We then
further analyzed the ThT intensity of individual ThT-active
aggregates from the TIRF data. The ThT intensity distribu-
tions showed the presence of two populations, high-intensity (H
species, peak at 15 a.u.) and low-intensity species (L species,
peak at <1 a.u.) (Fig. S2c†). It has been previously shown that the
H species appeared to be larger in size with a molecular weight
of >300 kDa (i.e. >12 PrP molecules), while the L species was
<300 kDa.35 These results indicate that the early-formed PrP
aggregates observed are mainly small-sized oligomers. It has to
be noted that long brils were not efficiently detected in our
TIRF imaging system, possibly due to the structural fragility of
PrP brils. However, these experiments provide structural
insights into early-formed oligomers based on ThT intensity of
individual aggregates and their PK resistance as discussed
below.
PrP oligomers undergo a PK-sensitive to PK-resistant
structural conversion
Next, we examined the PK susceptibility of the ThT-active
species as a function of time. The decrease of ThT intensity of
individual aggregates at dened time points was measured aer
1 h-proteolytic digestion (Fig. 4a–c). Most of the ThT-active
oligomers were initially PK-sensitive (PK-sen), and PK-
resistant species (PK-res) developed over time (Fig. 4c). The
initial ThT intensity of the aggregates before PK treatment
increased over time, suggesting the molecular size of PrP
aggregates increased over time, which is consistent with the
data shown in Fig. 1 and S2b†. Interestingly, the relationship
Fig. 1 (a) Super-resolved sPAINT images of PrP aggregates with Nile red (NR) at different time points. Monomeric PrP was incubated in a 1.5 mL
Eppendorf tube with 2 M GdnHCl at 37 Cwith 200 rpm. At various time points, aliquots were removed from the reactionmix and adsorbed onto
a glass coverslip for sPAINT imaging. The images are colored by the wavelength of individual NR fluorescence signals. The scale bars represent 1
mm, and those in the insets are 100 nm for 0.5, 3, and 8 h and 500 nm for fibrils at 48 h. (b) Length distribution of ThT-inactive and ThT-active PrP
species at different time points. The distributions shown correspond to the combined results of three independent measurements. The
maximum value in each distribution was normalized to 1. The overall number of analyzed PrP aggregates is as follows. At 0.5 h: NThT-inactive ¼ 13,
NThT-active ¼ 67; at 3 h: NThT-inactive ¼ 33, NThT-active ¼ 165; at 8 h: NThT-inactive ¼ 17, NThT-active ¼ 219; for fibrils at 48 h: NThT-active ¼ 231.
4590 | Chem. Sci., 2019, 10, 4588–4597 This journal is © The Royal Society of Chemistry 2019
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between PK resistance and the initial ThT intensity also sug-
gested that the H species of PrP aggregates were comprised of
both PK-sen and PK-res species (Fig. 4c). Next, we carried out
2D-Gaussian tting of the PK resistance data at different time
points and acquired the fraction and the number of the PK-sen/
PK-res species (Fig. 4d and e). Since the increase of the fraction
of the PK-res species was at the same rate as that of the decrease
of the PK-sen species, it suggested that there was a direct
structural conversion from the PK-sen to PK-res conformation.
To gain more insight between the correlation of PK resis-
tance and ThT intensity, we combined the PK resistance data
(Fig. 4d) with the ThT intensity distributions (Fig. S2c†). The PK-
sen and PK-res oligomers could be further sub-classied based
on their ThT intensity, either L or H. Therefore, four oligomeric
Fig. 2 (a) Hydrophobicity distribution of ThT-inactive and ThT-active PrP species at different time points. The median wavelength of Nile red
(NR) fluorescence derived from all binding events to a single PrP aggregate was determined to measure the hydrophobicity of individual
aggregates. (b) Hydrophobicity landscapes of individual PrP aggregates plotted as a function of their length. The landscape plots are colored by
the population density of the aggregates. The distributions shown correspond to the accumulation of three independent measurements. (c)
Number of aggregates identified from sPAINT images as a function of time. (d) Median wavelength of NR fluorescence for individual aggregates
as a function of time. The bars represent mean values and standard deviations from three independent experiments. The maximum value in each
distribution was normalized to 1. The overall number of analyzed PrP aggregates is as follows. At 0.5 h: NThT-inactive¼ 44, NThT-active¼ 403; at 3 h:
NThT-inactive ¼ 36, NThT-active ¼ 199; at 8 h: NThT-inactive ¼ 24, NThT-active ¼ 261; for fibrils at 48 h: NThT-active ¼ 341.
This journal is © The Royal Society of Chemistry 2019 Chem. Sci., 2019, 10, 4588–4597 | 4591
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species were found: (1) PK-sen/low-intensity (SL); (2) PK-sen/
high-intensity (SH); (3) PK-res/low-intensity (RL); and (4) PK-
res/high-intensity (RH). Combining their kinetic data, we
showed that at the early stage of PrP aggregation, the number of
RL and RH increased with time, in contrast to SL and SH, which
remained unchanged at a low level (Fig. S2d†).
PK-sensitive oligomers are more capable of disrupting the
lipid membrane than brils
The oligomeric aggregates of PrP have been shown to be more
toxic than brils both in vitro and in vivo.28,36,37 From biophysical
studies and computer simulations on other aggregated
proteins,13,38–44 the origin of the cytotoxicity is suggested to be
non-specic membrane disruption. This partially permeabilizes
the lipid membrane of cells, resulting in Ca2+ inux and the
disruption of cellular homeostasis.13,15,39,42,43,45,46 To study the
potential damaging effect of protein aggregates on lipid
membranes, we have recently developed an assay to quantify
the ability of aggregates to permeabilize membranes, by
measuring the inux of external Ca2+ ions with a liposome-
encapsulated Ca2+-binding dye.47 Using this approach, we
have quantied the membrane disruption of toxic aggregates of
Ab43 and a-synuclein,48 tau,49 as well as those in human cere-
brospinal uid (CSF) from Alzheimer's disease patients.50
We applied PrP aggregates at dened time points onto
liposomes that attach to a coverslip surface and then measured
the membrane permeabilization induced by the aggregates. In
Fig. 5, the membrane permeabilization was normalized by the
average number of the aggregates observed in the TIRF images.
For the mature brils collected aer 48 h of aggregation, the
membrane permeabilization per aggregate was found to be 4-
fold lower than the small-sized aggregates formed at early
stages of aggregation. This suggested the inefficiency of PrP
brils in permeabilizing lipid membranes. In contrast, the
early-formed aggregates saw a constant high capability of
membrane permeabilization with little change at early aggre-
gation times. This suggested that the PK-res species (RL and RH)
were less likely to be responsible for the disruption of lipid
membranes, as their number increased dramatically over time
(Fig. 4e). Instead, the two types of PK-sen species (SL and SH)
and ThT-inactive species, which all maintained constant
numbers over time (Fig. 2c and 4e), were more likely to be the
main cause of membrane permeabilization.
Discussion
The study of the spatial distribution and temporal evolution of
the infectious and toxic PrP species is important and requires
direct studies of infectivity and toxicity and identication of the
species responsible. However, physical characterization of the
PrP species has proved to be technically challenging. Single-
aggregate imaging methods provide an in vitro approach to
characterize the various species of PrP aggregates. We have
explored the aggregation kinetics of recombinant PrP at early
stages under partially denaturing conditions. According to our
measurements, ve oligomeric species with distinct structural
characteristics have been identied: (1) PK-sen/low-intensity
oligomers (SL); (2) PK-sen/high-intensity oligomers (SH); (3)
PK-res/low-intensity oligomers (RL); (4) PK-res/high-intensity
oligomers (RH); and (5) ThT-inactive oligomers. The presence
of SL, SH, and ThT-inactive oligomers at early times and their
constant numbers during aggregation suggests that they are in
kinetic equilibrium with monomers. In contrast, from the
temporal change of PK-sen and PK-res species in Fig. 4d, it is
suggested that SL and SH undergo a structural conversion to RL
and RH, independently, despite the L and H species appearing
to have a similar kinetic behavior at early aggregation times
within 8 h (Fig. S2c and d†).
The quantitative TIRF data provided structural information
of ThT-active PrP aggregates with high temporal resolution.
Kinetic analysis is an important approach that can be used to
determine the microscopic mechanism of the aggregation
reaction. The data were analyzed by tting to a kinetic model for
protein aggregation15,51–53 (Fig. 6; see Methods and materials for
the derivation of the model). Compared to the previous model
for a-synuclein aggregation,53 the kinetics for PrP aggregation
(Fig. 6a) contains reversible reactions that cannot be neglected
and follows a nucleation–dissociation–conversion model. This
is similar to the previous work with the yeast prion Ure2, which
dissociates back to monomers during the initial nucleation
process.29 In the kinetic model for the early stage of PrP aggre-
gation, SL and SH share similar kinetic parameters, as do RL and
RH (Table 1). This suggests that the L and H species are likely to
interconvert on the time scale of the measurements. Therefore
for convenience, the model can be simplied to that shown in
Fig. 6b, where SL and SH are treated as a single species, as are RL
and RH. Based on this simplied model, the tted kinetic
Fig. 3 Accumulated hydrophobicity landscapes of ThT-inactive and ThT-active PrP species over all time points compared to mature fibrils
formed after 48 h aggregation. The landscape plots are colored by the population density of the aggregates. The overall number of analyzed PrP
aggregates is as follows: NThT-inactive ¼ 103, NThT-active ¼ 863, NThT-active for fibrils at 48 h ¼ 341.
4592 | Chem. Sci., 2019, 10, 4588–4597 This journal is © The Royal Society of Chemistry 2019
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parameters are shown in Table 2. This means the half-life for
PK-sen / PK-res conversion is roughly 1 hour under our
aggregation conditions. Our previous measurement for
a-synuclein15 gave the half-life for the PK-sen / PK-res
conversion as about 36 hours, which is slower than that for
PrP by an order of magnitude. The fast conversion rate for PrP
Fig. 4 Time-dependent increase of Proteinase K (PK) resistance during PrP aggregation in the presence of 2 M GdnHCl at 37 C with shaking at
200 rpm. The ThT intensity distributions of PrP aggregates at different time points (a) before and (b) after PK treatment. PK was added at different
times to the glass surface that contained the PrP aggregates and the slide chamber sealed to prevent fluid evaporation. The change in ThT
intensity of individual particles was followed by continual imaging with the fixed field of views at 37 C incubation. Normalized PK resistance was
calculated as the fraction of the ThT intensity after 1 h proteolytic digestion compared to that seen at the start of the measurement. (c) The PK
resistance of individual aggregate plotted against their initial intensity. The plots shown correspond to the combined results of three independent
measurements. The PK resistance landscape plots were globally fitted to 2D-Gaussian functions to estimate the fraction of PK-sen and PK-res
species. Change in (d) the fraction and (e) the number of PK-sen and PK-res species of PrP aggregates were then plotted as a function of time.
The error bars represent standard deviations from three independent experiments.
This journal is © The Royal Society of Chemistry 2019 Chem. Sci., 2019, 10, 4588–4597 | 4593
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may be partially due to the semi-denaturing condition, but still,
it suggests that the conversion rate is fundamentally faster in
the case of PrP.
It is not surprising that in the absence of a PrPSc template,
the aggregation of recombinant PrP results in a range of
abnormal b-sheet-rich isoforms. Many biochemical studies
have been carried out to generate and characterize PrP oligo-
mers in vitro, although these oligomers were oen obtained
under variable aggregation conditions and from different
versions of PrP. Two types of PrP oligomers have been shown to
be kinetically stable and do not form brils.16–20 This may be due
to recombinant PrP that is trapped in kinetic local maxima
during the unfolding/refolding steps. PrP oligomerization has
previously been followed either on a mica or gold surface.54–56
However, it is unclear if the oligomers formed on a hydrophilic
surface in these experiments eventually form brils or show
similar structural characteristics to oligomers obtained in other
studies. Furthermore, the use of truncated versions of PrP and
the lack of co-factors may also contribute to increasing the
chance of being trapped in local maxima. In the present study,
full-length PrP aggregation has been carried out under
a condition that favors the formation of amyloid brils.
Therefore, at least a fraction of the ThT-active oligomers
observed is likely to be on-pathway intermediates to bril
formation. Considering the ThT-inactive species, a previous
study reports that they are off the pathway to brils.57 This is
different from current ndings, where we observe that the ThT-
inactive species undergo a structural transition to a more
hydrophobic conformation. Our observation of an unchanged
number of the ThT-inactive species suggests that they may be at
equilibrium with other aggregate species, some of which
undergo a structural conversion and continue to form brils.
The small changes in the number of total oligomeric pop-
ulations formed at the early stage of aggregation suggest that
many of them stay in the soluble state and can dissociate back
Fig. 5 Membrane permeability per PrP aggregate as a function of
time. Monomeric PrP was aggregated at a concentration of 27.5 mM in
the presence of 2 M GdnHCl at 37 Cwith shaking at 200 rpm. At each
time point, an aliquot was taken, diluted to a final concentration of
50 nM, and loaded onto a liposome-attached slide surface. The fibrils
were collected at 48 h by centrifugation. The increase of Cal-520
(Ca2+-binding dye) fluorescence was determined as Ca2+ influx and
was calibrated with blank background and ionomycin control as
described in the Methods. The Ca2+ influx from individual experiments
was then normalized with the number of ThT-active PrP aggregates
observed from TIRF images. The relative influx level at 0.5 h was set as
1. The error bars represent standard deviations from three independent
experiments.
Fig. 6 Modeling the kinetics of PrP aggregation. (a) The kinetic
model considers the nucleation of PK-sensitive species (S) from the
monomer (m) is in equilibrium, and a structural conversion reaction
happens between oligomeric populations. (b) A simplified kinetic
model that considers a single S / R population, as L and H share
similar kinetic parameters. The S species includes SL (low-intensity)
and SH (high-intensity), while the R species includes RL (low-inten-
sity) and RH (high-intensity). (c) Global fits of the kinetic profiles of
PrP aggregation using the nucleation–dissociation–conversion
model with a single S / R population. K, equilibrium constant; n,
reaction order of nucleation; kc, rate constant of conversion from S
to R; nc, reaction order of conversion; kd, rate constant of reverse
reaction of conversion. See Methods and materials for the derivation
of the model.
Table 1 Fitted parameters for the kinetic model of PrP aggregation. In
this model, the L and H species are nucleated from monomers and
have independent aggregation reactions (i.e. SL / RL; SH / RH). K,
equilibrium constant; n, reaction order of nucleation; kc, rate constant
of PK-sen/ PK-res conversion; nc, reaction order of conversion; kd,
rate constant of reverse reaction of conversion
K (count per mM) n kc (h
1) nc kd (h
1)
L 120 1 0.80 0 0.40
H 69 1 0.93 0 0.23
Table 2 Fitted parameters for the simplified kinetic model of PrP
aggregation. In the simplifiedmodel, the L and H species are treated as
a single species due to their similar kinetics. The PK-sensitive species is
formed by monomer nucleation and then converts to PK-resistant
species. K, equilibrium constant; n, reaction order of nucleation; kc,
rate constant of PK-sen / PK-res conversion; nc, reaction order of
conversion; kd, rate constant of reverse reaction of conversion
K (count per mM) n kc (h
1) nc kd (h
1)
Total (L + H) 189 1 0.77 0 0.27
4594 | Chem. Sci., 2019, 10, 4588–4597 This journal is © The Royal Society of Chemistry 2019
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to monomers. It is likely that only a minor fraction of the PK-res
oligomers grow into mature brils. Apart from the molecular
size (based on the observation from ThT intensity distribution),
it is difficult to distinguish them using other structural
approaches, such as surface hydrophobicity or PK resistance,
indicating that L and H species have similar conformations.
Despite the L and H species showing similar kinetics, the
fraction of the H species decreased at 48 h when bril formation
reached a plateau (Fig. S2c†), suggesting that it is the H species
(>300 kDa), that ultimately grows to mature brils. Studies of
the puried hamster PrPSc support this concept since its olig-
omeric forms appear to form two species with different
molecular sizes. The molecular weight of the most infectious
PrP aggregates is found to be 300 to 600 kDa (comprising 14–
28 PrP molecules),25,27 while the small oligomeric species is
100 to 150 kDa (comprising 4–6 PrP molecules) and is not
infectious.27,58
Detailed elucidation of the ultrastructure of PrPSc has been
hindered largely due to the difficulties in obtaining sufficient
amounts of this aggregated species. Several structures for PrPSc
have been proposed based on a variety of different experimental
approaches.59–66 There are two main competing models where
the structure of PrPSc contains either a parallel in-register
intermolecular b-sheet (PIRIBS)62,67 or a b-solenoid66,68 archi-
tecture. Based on the current data, we can discuss the structural
properties of our PrP aggregates in the context of these two
models. It is important to note that our recombinant PrP
aggregates were obtained using semi-denaturing conditions,
similar to those used for generating PrP brils with a parallel in-
register structure.32 Compared to PrPC, PrPSc is usually partially
resistant to PK digestion in the C-terminal portion of the
molecule, indicating the existence of a highly stable inter-
molecular interaction within a single aggregate.69 PK resis-
tance of PrPSc has been shown to be strongly dependent on the
quaternary structure of PrPSc.25,70 The increase of PK resistance
in Fig. 4 suggests that recombinant PrP adopts a more compact
high-ordered structure during the formation of brils. This is
unlikely to be due to the increased molecular size, because we
did not see a correlation between PK resistance and the accu-
mulation of L/H oligomers. From Fig. 2, the surface hydro-
phobicity of the ThT-active aggregates does not show a clear
change over time and is similar to that of mature brils. This
indicates that despite the increase of PK resistance, the exposed
regions of individual monomers in the brils is similar to that
in early-formed oligomers. The oligomers are unlikely to have
the compact b-solenoid structure,66,71 since this has less exposed
residues and is expected to be highly PK-resistant. In contrast,
the parallel in-register model62,67 has extended loops and hair-
pins exposed to solvent molecules. Therefore, if the PrP oligo-
mers adopt a parallel in-register structure during the transition
to brils, the surface hydrophobicity would remain constant,
while PK resistance would increase due to the increase of the
inter-molecular interaction between monomers in the aggre-
gate, which is consistent with our results.
Although the origin of the cytotoxicity induced by aggregated
proteins might be complicated, it appears to be highly corre-
lated to the ability of the aggregates to disrupt lipid membranes
of cellular components. The membrane permeability assay
represents a means to quantitatively measure the ability of PrP
aggregates to permeabilize lipid membranes and to determine
the most effective species. Our data show that early-formed PrP
oligomers possess higher membrane permeability than mature
brils and that the ThT-inactive or PK-sen oligomers are likely
to be responsible for inducing calcium inux in membranes.
This is consistent with previous ndings that toxic oligomers
are structurally loosely-packed39 and that they may result from
PK-sen species.22 It also suggests that these toxic species of PrP
aggregates may include ThT-inactive species, which are present
at a low level, relatively small in size, and technically difficult to
detect. Therefore, despite the fact that the current measurement
is based on in vitro aggregation of PrP which does not involve co-
factors and translational modications, this work provides
important insights into the complexity of PrP aggregation at
early stages of aggregation and the structure of the aggregates
formed. However, the difference between bona de prions and
the currently observed PrP oligomers remains to be elucidated.
Overall, our work reveals that at least ve types of aggregates
can co-exist during PrP aggregation. The ThT-inactive oligomers
and PK-sen oligomers remain at a constant number over time
and are better at disrupting lipid membranes and inducing Ca2+
inux. In contrast, PK-res oligomers are likely formed by
a structural conversion from the PK-sen species and are likely to
form brils. According to ThT intensity, the structurally
different PK-sen/PK-res species can be sub-divided into the L
and H species, which are different in size and yet share a similar
kinetic behavior. Therefore, PrP amplication and lipid
membrane disruption are likely mediated by different aggregate
species with distinct structural properties. This study provides
insights into prion diversity and why some protein aggregates
can act as efficient pathogens whereas others cannot. Despite
requiring further studies in vivo, these aggregate species iden-
tied can be specic targets for therapeutic intervention.
Therefore, reducing the population of the specic oligomeric
species or promoting their removal pathways can be potentially
important for inhibiting the aggregation process of PrP
propagation.
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